Literature DB >> 24286971

The availability of glucose to CHO cells affects the intracellular lipid-linked oligosaccharide distribution, site occupancy and the N-glycosylation profile of a monoclonal antibody.

Bo Liu1, Maureen Spearman1, John Doering1, Erica Lattová2, Hélène Perreault2, Michael Butler3.   

Abstract

The glycosylation pattern of a chimeric heavy chain antibody (EG2) produced from CHO cells was affected by the glucose concentration (0-25mM) of cultures established at high density (>10(6)ml(-1)) over 24h. The resulting proportion of non-glycosylated Mab was directly correlated to the exposure time of cells to media depleted of glucose. Deprivation of glucose for the full 24h resulted in a 45% non-glycosylated Mab fraction. Analysis of steady state levels of intracellular lipid-linked oligosaccharides (LLOs) showed that under glucose limitation there was a reduction in the amount of full length LLO (Glc3Man9GlcNac2), with a concomitant increase in the smaller mannosyl-glycans (Man2-5GlcNAc2). Glycan microheterogeneity was quantified by galactosylation and sialylation indices (GI and SI) which showed a direct correlation to the cell specific glucose uptake. The GI increased to 0.83 following media supplementation with a cocktail of uridine, manganese and galactose. This is significantly higher than for a fully humanized antibody (DP12) produced under the similar conditions or for similar antibodies reported in the literature. The high GI of the chimeric antibody (EG2) may be due to its low molecular weight and unusual structure. These findings are important in relation to the low substrate that may occur in fed-batch cultures for Mab production.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  CHO cells; Glycosylation; Lipid-linked oligosaccharide; Monoclonal antibody

Mesh:

Substances:

Year:  2013        PMID: 24286971     DOI: 10.1016/j.jbiotec.2013.11.007

Source DB:  PubMed          Journal:  J Biotechnol        ISSN: 0168-1656            Impact factor:   3.307


  19 in total

Review 1.  The therapeutic monoclonal antibody market.

Authors:  Dawn M Ecker; Susan Dana Jones; Howard L Levine
Journal:  MAbs       Date:  2015       Impact factor: 5.857

2.  Animal Cell Expression Systems.

Authors:  M Butler; U Reichl
Journal:  Adv Biochem Eng Biotechnol       Date:  2021       Impact factor: 2.635

3.  A simultaneous assessment metric for MAb quantity and glycan quality.

Authors:  Gerald Drouillard; Gordon Hayward; Julie Vale; Roshni Dutton
Journal:  Cytotechnology       Date:  2016-08-09       Impact factor: 2.058

4.  Cooperative roles of glucose and asparagine-linked glycosylation in T-type calcium channel expression.

Authors:  Joanna Lazniewska; Yuriy Rzhepetskyy; Fang-Xiong Zhang; Gerald W Zamponi; Norbert Weiss
Journal:  Pflugers Arch       Date:  2016-09-23       Impact factor: 3.657

5.  Cell Free Remodeling of Glycosylation of Antibodies.

Authors:  Letícia Martins Mota; Venkata S Tayi; Michael Butler
Journal:  Methods Mol Biol       Date:  2022

6.  A semi-empirical glycosylation model of a camelid monoclonal antibody under hypothermia cell culture conditions.

Authors:  Hengameh Aghamohseni; Maureen Spearman; Kaveh Ohadi; Katrin Braasch; Murray Moo-Young; Michael Butler; Hector M Budman
Journal:  J Ind Microbiol Biotechnol       Date:  2017-03-11       Impact factor: 3.346

7.  Biochemical Characterization of Human Anti-Hepatitis B Monoclonal Antibody Produced in the Microalgae Phaeodactylum tricornutum.

Authors:  Gaëtan Vanier; Franziska Hempel; Philippe Chan; Michael Rodamer; David Vaudry; Uwe G Maier; Patrice Lerouge; Muriel Bardor
Journal:  PLoS One       Date:  2015-10-05       Impact factor: 3.240

8.  N-glycosylation of cholera toxin B subunit in Nicotiana benthamiana: impacts on host stress response, production yield and vaccine potential.

Authors:  Krystal Teasley Hamorsky; J Calvin Kouokam; Jessica M Jurkiewicz; Bailey Nelson; Lauren J Moore; Adam S Husk; Hiroyuki Kajiura; Kazuhito Fujiyama; Nobuyuki Matoba
Journal:  Sci Rep       Date:  2015-01-23       Impact factor: 4.379

9.  A theoretical estimate for nucleotide sugar demand towards Chinese Hamster Ovary cellular glycosylation.

Authors:  Ioscani Jimenez Del Val; Karen M Polizzi; Cleo Kontoravdi
Journal:  Sci Rep       Date:  2016-06-27       Impact factor: 4.379

10.  Understanding and Controlling Sialylation in a CHO Fc-Fusion Process.

Authors:  Amanda M Lewis; William D Croughan; Nelly Aranibar; Alison G Lee; Bethanne Warrack; Nicholas R Abu-Absi; Rutva Patel; Barry Drew; Michael C Borys; Michael D Reily; Zheng Jian Li
Journal:  PLoS One       Date:  2016-06-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.